FIRM FIXED PRICENO SET ASIDE USED.
A-S MEDICATION SOLUTIONS LLC - NEW AWARD FOR CEFUROXIME AXETIL TABLETS WITH A-S MEDICATION SOLUTIONS. ORDERING PERIOD IS MARCH 28, 2026 THROUGH MARCH 27, 2027 WITH FOUR ONE-YEAR OPTIONS.
PIID: 36E79726D0008Solicitation ID: 36E79725R0059
Signed Date: Dec 18, 2025Effective Date: Mar 28, 2026
Key Details
Description
NEW AWARD FOR CEFUROXIME AXETIL TABLETS WITH A-S MEDICATION SOLUTIONS. ORDERING PERIOD IS MARCH 28, 2026 THROUGH MARCH 27, 2027 WITH FOUR ONE-YEAR OPTIONS.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.